Abstract:This study examined the effects of metformin (MF) and trodusquemine (MSI‐1436) on the livers of young, developing mice. We discovered that MSI‐1436 significantly alters mRNA and miRNA expression more potently than MF, impacting key metabolic pathways. These findings suggest that these early life interventions can metabolically reprogram the liver during the postnatal window through significant epigenetic modifications, thereby potentially forestalling the onset of age‐related diseases to promote healthspan and extend lifespan. Recent studies have demonstrated the remarkable potential of early life intervention strategies at influencing the course of postnatal development, thereby offering exciting possibilities for enhancing longevity and improving overall health. Metformin (MF), an FDA‐approved medication for type II diabetes mellitus, has recently gained attention for its promising anti‐aging properties, acting as a calorie restriction mimetic, and delaying precocious puberty. Additionally, trodusquemine (MSI‐1436), an investigational drug, has been shown to combat obesity and metabolic disorders by inhibiting the enzyme protein tyrosine phosphatase 1b (Ptp1b), consequently reducing hepatic lipogenesis and counteracting insulin and leptin resistance. In this study, we aimed to further explore the effects of these compounds on young, developing mice to uncover biomolecular signatures that are central to liver metabolic processes. We found that MSI‐1436 more potently alters mRNA and miRNA expression in the liver compared with MF, with bioinformatic analysis suggesting that cohorts of differentially expressed miRNAs inhibit the action of phosphoinositide 3‐kinase (Pi3k), protein kinase B (Akt), and mammalian target of rapamycin (Mtor) to regulate the downstream processes of de novo lipogenesis, fatty acid oxidation, very‐low‐density lipoprotein transport, and cholesterol biosynthesis and efflux. In summary, our study demonstrates that administering these compounds during the postnatal window metabolically reprograms the liver through induction of potent epigenetic changes in the transcriptome, potentially forestalling the onset of age‐related diseases and enhancing longevity. Future studies are necessary to determine the impacts on lifespan and overall quality of life.

A Mechanistic Analysis of Metformin's Biphasic Effects on Lifespan and Healthspan in C. Elegans: Elixir in Youth, Poison in Elder

Metformin Extends C. Elegans Lifespan Through Lysosomal Pathway.

Effect of Metformin on Cardiac Metabolism and Longevity in Aged Female Mice

228-LB: Metformin Alleviates Aging-Associated Metabolic Disorders through Intestinal AMPK-Mediated Gut Microbiome Alteration

Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity

Metformin treatment of juvenile mice alters aging-related developmental and metabolic phenotypes in sex-dependent and sex-independent manners

Metformin decelerates aging clock in male monkeys

Effects of Metformin on Life Span, Cognitive Ability, and Inflammatory Response in a Short-Lived Fish

Metformin prolongs lifespan through remodeling the energy distribution strategy in silkworm, Bombyx mori

Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations

Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans

Repurposing metformin: an old drug with new tricks in its binding pockets

Metformin prevents murine ovarian aging

Metformin: a metabolic modulator

Novel Metabolites that Modulate Aging and Aging-related Symptoms

Meta-analytic Insights into the Effects of Different Anti-aging Drugs on Survival Curves of Caenorhabditis elegans

Metformin Protects PC12 Cells and Hippocampal Neurons from H2O2‐induced Oxidative Damage Through Activation of AMPK Pathway

Metformin: From diabetes to cancer to prolongation of life